When is a patient too well and when is a patient too sick for a liver transplant

Liver Transplantation

Volumn 10, Issue 10 SUPPL. 2, 2004, Pages

  Merion, Robert M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE MODEL; DISEASE SEVERITY; GRAFT SURVIVAL; HEALTH CARE POLICY; HUMAN; LIFE EXPECTANCY; LIVER DISEASE; LIVER TRANSPLANTATION; MORTALITY; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; RECIPIENT; RESOURCE ALLOCATION; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SURVIVAL RATE; SYSTEMATIC REVIEW;

DECISION SUPPORT TECHNIQUES; HEALTH CARE RATIONING; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; MODELS, STATISTICAL; PROGNOSIS; SEVERITY OF ILLNESS INDEX; WAITING LISTS;

EID: 6444226460     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20265     Document Type: Article

References (15)

1. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124:91-96.
2. Freeman RB, Jr, Wiesner RH, Harper A, McDiarmid SV, Lake J, Edwards E, et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 2002;8:851-858.
3. Saab S, Wang V, Ibrahim AB, Duranzo F, Han S, Farmer DG, et al. MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transpl 2003;9:473-476.
4. Desai NM, Mange KC, Crawford MD, Abt P, Frank AM, Markmann J, et al. Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation 2004;77:99-106.
5. Onaca NN, Levy MF, Sanchez EQ, Chinnaketla S, Fasala CG, Thomas MJ, et al. A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl 2003;9:117-123.
6. Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA. The survival benefit of liver transplantation. Am J Transplant 2004;4(Suppl 8):308.
7. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Tharnaeu TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-470.
8. Wiesner RH, McDiarmid SV, Kamath PS, Edwards EB, Malinochos M, Kramers WK, et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl 2001;7:567-580.
9. McDiarmid SV, Anand R, Lindblad AS, The Principal Investigators and Institutions of the Studies of Pediatric Liver Transplantation Research Group. Development of a pediatric endstage liver disease score to predict poor outcome in children awaiting liver transplantation. Transplantation 2002;74:173-181.
10. Merion RM, Wolfe RA, Dykstra DM, Leichtman AB, Gillespie B, Held PJ. Longitudinal assessment of mortality risk among candidates for liver transplantation. Liver Transpl 2003;9:12-18.
11. Dykstra DM, Wiesner RH, Port FK, Wolfe RA, Merion RM. Improvements in the model for end-stage liver disease (MELD) severity score. Am J Transplant 2004;4(Suppl 8):516.
12. Ruf AE, Yantorno SE, Descalzi VI, Andriani OC, Podesta LG, Villamil FG. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone: a single-center experience. Am J Transplant 2004;4(Suppl 8):438.
13. Shaw BW, Jr, Wood RP, Gordon RD, Iwatsuki S, Gillquist WP, Starzl TE. Influence of selected patient variables and operative blood loss on six-month survival following liver transplantation. Semin Liver Dis 1985;5:385-393.
14. Baliga P, Merion RM, Turcotte JG, Ham TM, Henley KS, Way MR, et al. Preoperative risk factor assessment in liver transplantation. Surgery 1992;112:704.
15. Olthoff KM, Brown RS, Jr, Delmonico FL, Freeman R, McDiarmid J, Merion RM, et al. Summary report of a national conference: evolving concepts in liver allocation in the MELD/PELD era. Liver Transpl 2004;10(suppl 2):A6-A22.